Get the Stockscreener App
63.12
0.86%
-0.55
Pre-market:
63.45
0.33
+0.52%
Caredx Inc stock is traded at $63.12, with a volume of 900.20K.
It is down -0.86% in the last 24 hours and up +25.59% over the past month.
CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically it generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.
See More
Previous Close:
$63.67
Open:
$63.28
24h Volume:
900.20K
Relative Volume:
0.59
Market Cap:
$3.27B
Revenue:
$412.82M
Net Income/Loss:
$-8.19M
P/E Ratio:
-409.60
EPS:
-0.1541
Net Cash Flow:
$64.17M
1W Performance:
-1.05%
1M Performance:
+25.59%
6M Performance:
+275.04%
1Y Performance:
+334.41%
1-Day Range:
$0.00
$0.00
1-Week Range:
$61.19
$65.13
52-Week Range:
$13.95
$72.51
Caredx Inc Stock (CDNA) Company Profile
Name
Caredx Inc
Sector
Industry
Phone
415-287-2300
Address
8000 MARINA BLVD, BRISBANE, CA
Compare CDNA vs TMO, DHR, NTRA, A, IQV
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CDNA
Caredx Inc
|
63.12 | 3.27B | 412.82M | -8.19M | 64.17M | -0.1541 |
TMO
Thermo Fisher Scientific Inc
|
662.24 | 244.86B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
221.20 | 155.50B | 24.78B | 3.68B | 5.29B | 5.1743 |
NTRA
Natera Inc
|
397.77 | 57.34B | 2.50B | -226.32M | 71.51M | -1.6412 |
A
Agilent Technologies Inc
|
171.33 | 48.30B | 7.23B | 1.41B | 1.09B | 4.979 |
IQV
Iqvia Holdings Inc
|
262.21 | 43.16B | 16.63B | 1.39B | 2.12B | 8.0674 |
Caredx Inc Stock (CDNA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-02-26 | Initiated | Canaccord Genuity | Buy |
| Aug-03-26 | Upgrade | Craig Hallum | Hold → Buy |
| Jan-06-26 | Downgrade | Craig Hallum | Buy → Hold |
| Aug-26-25 | Initiated | William Blair | Mkt Perform |
| Jan-15-25 | Upgrade | Wells Fargo | Underweight → Equal Weight |
| Aug-28-24 | Initiated | Wells Fargo | Underweight |
| Aug-19-24 | Upgrade | BTIG Research | Neutral → Buy |
| May-13-24 | Downgrade | Raymond James | Outperform → Mkt Perform |
| May-01-24 | Upgrade | Craig Hallum | Hold → Buy |
| Nov-09-23 | Upgrade | Stephens | Equal-Weight → Overweight |
| Aug-15-23 | Upgrade | Raymond James | Mkt Perform → Outperform |
| May-11-23 | Downgrade | BTIG Research | Buy → Neutral |
| Mar-07-23 | Downgrade | Stephens | Overweight → Equal-Weight |
| Mar-03-23 | Downgrade | Craig Hallum | Buy → Hold |
| Mar-03-23 | Downgrade | Raymond James | Strong Buy → Mkt Perform |
| Apr-25-22 | Initiated | Stephens | Overweight |
| Jul-20-21 | Resumed | BTIG Research | Buy |
| Jun-03-21 | Initiated | Goldman | Buy |
| Feb-26-21 | Downgrade | H.C. Wainwright | Buy → Neutral |
| Oct-30-20 | Reiterated | H.C. Wainwright | Buy |
| Oct-08-20 | Reiterated | H.C. Wainwright | Buy |
| Oct-02-20 | Reiterated | H.C. Wainwright | Buy |
| Aug-05-20 | Reiterated | H.C. Wainwright | Buy |
| Jun-26-20 | Initiated | BTIG Research | Buy |
| Jun-19-20 | Reiterated | H.C. Wainwright | Buy |
| Oct-01-19 | Resumed | Craig Hallum | Buy |
| May-09-19 | Upgrade | H.C. Wainwright | Neutral → Buy |
| Feb-15-19 | Initiated | Jefferies | Buy |
| Oct-23-18 | Resumed | Raymond James | Strong Buy |
| Sep-18-18 | Reiterated | H.C. Wainwright | Neutral |
| Nov-27-17 | Initiated | H.C. Wainwright | Buy |
| Jun-14-16 | Reiterated | Mizuho | Buy |
| Sep-29-15 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Sep-25-15 | Initiated | Craig Hallum | Buy |
| Mar-18-15 | Reiterated | Mizuho | Buy |
View All
Caredx Inc Stock (CDNA) Latest News
A Look at CareDx Inc (CDNA) After 4.0% Gain -- GF Value $25.50 v - GuruFocus
Form 4 Caredx Inc For: 5 October By Investing.com - Investing.com South Africa
CareDx General Counsel Reports Withholding of Shares for RSU Tax Obligations - Kalkine Media
CareDx CEO John Walter Withholds 8,511 Shares for Tax on RSU Vesting - Kalkine Media
Stock vesting triggers 997-share tax withholding for CareDx (CDNA) counsel Jeffrey Adam Novack. - Stock Titan
CareDx CCO Jessica Meng Withholds 2,619 Shares for RSU Tax on October 1, 2026 - Kalkine Media
After 8,511 shares were withheld for taxes, CareDx (CDNA) CEO holds 644,937 shares directly. - Stock Titan
Tax withholding leaves CareDx (CDNA) CFO Keith Kennedy with 208,686 directly held shares. - Stock Titan
For stock-vesting taxes, CareDx (CDNA) withholds 2,619 shares from its chief commercial officer. - Stock Titan
A 588-share grant replaces cash pay for CareDx (CDNA) director Michael Goldberg. - Stock Titan
Immunogenomics Market Size, Share, Trends, and Growth Forecast, 2026-2033 | NGS and Personalized Medicine Drive Market Toward USD 9.82 Billion at 5.97% CAGR - GlobeNewswire Inc.
Biotech Stocks At 52-Week HighsCDNA, RCEL, AZTA, HNGE - RTTNews
CareDx, Inc (CDNA) stock price, news, quote and history - Yahoo Finance UK
Caredx Inc stock hits 52-week high at 65.53 USD - Investing.com
Caredx Inc stock hits 52-week high at 65.53 USD By Investing.com - Investing.com Canada
Caredx Inc stock hits 52-week high at 65.53 USD By Investing.com - Investing.com UK
Consumer Confidence Falls Amid Ongoing Geopolitical Tensions: 4 Picks - Zacks Investment Research
Consumer Confidence Falls Amid Ongoing Geopolitical Tensions: 4 Picks - es.tradingview.com
CareDx, Inc. (CDNA) Stock Price, News, Quote & History - Yahoo! Finance Canada
CareDx Refocused On Transplant Testing, And Wall Street Noticed - Finimize
CareDx, Inc. (CDNA) stock price, news, quote and history - Yahoo Finance Singapore
CareDx: I Was Wrong, But The Rally Has Outrun The Fundamentals (Rating Upgrade) - Seeking Alpha
CareDx (CDNA) Stock Jumps 13.0%: Will It Continue to Soar? - Yahoo Finance
CareDx Inc (CDNA) Stock Up 13.0% but GF Value Says Overvalued -- GF Score: 66/100 - gurufocus.com
CareDx +14% on Fresh $74 Analyst Price Target - Yahoo Finance
BTIG raises CareDx stock price target to $74 on transplant outlook - Investing.com
Zacks.com featured highlights include CareDx, Ciena, Celestica, Materion and MACOM Technology Solutions - Yahoo Finance
Medicare Lab Fee Changes Impact BillionToOne, CareDx Differently - Benzinga
A Look at CareDx Inc (CDNA) After 4.0% Gain -- GF Value $25.41 v - gurufocus.com
Caredx Inc stock hits 52-week high at 55.21 USD - Investing.com
CAREDX INC (NASDAQ:CDNA): High Growth and Improving Fundamentals Fuel Bullish Case - ChartMill
CareDx, Inc. (CDNA) Investor Outlook: Riding High with a 52.20% Revenue Growth in the Healthcare Sector - DirectorsTalk Interviews
CareDx (CDNA) CFO uses 8,220 shares to cover RSU taxes - Stock Titan
Caredx Inc stock hits 52-week high at 53.71 USD - Investing.com
CareDx (NASDAQ: CDNA) CCO has 6,688 shares withheld for taxes - Stock Titan
CareDx (NASDAQ:CDNA) Meets Minervini Trend Template with High-Growth Momentum - ChartMill
Oil Surge Continues on Escalating Middle East Crisis: 4 Defensive Picks - TradingView
Are Medical Stocks Lagging CareDx (CDNA) This Year? - Yahoo Finance
Technical Reactions to CDNA Trends in Macro Strategies - Stock Traders Daily
CareDx (NASDAQ:CDNA) Screens Well on High Growth Momentum and Breakout Setup - ChartMill
CDNA Initiates Coverage by Canaccord Genuity -- Price Target Set at $65 - GuruFocus
Canaccord Genuity Initiates Coverage of CareDx, BillionToOne With Buy Ratings - GenomeWeb
Canaccord initiates CareDx stock coverage with buy rating on testing By Investing.com - Investing.com South Africa
Canaccord initiates CareDx stock coverage with buy rating on testing By Investing.com - Investing.com Nigeria
Canaccord Genuity Initiates CareDx at Buy With $65 Price Target - marketscreener.com
Canaccord initiates CareDx stock coverage with buy rating on testing - Investing.com India
Canaccord initiates CareDx stock coverage with buy rating on testing - investing.com
CareDx (CDNA) is a Great Momentum Stock: Should You Buy? - Eastern Progress
CareDx (CDNA) is a Great Momentum Stock: Should You Buy? - Yahoo Finance
Caredx Inc stock hits 52-week high at 49.77 USD By Investing.com - Investing.com Canada
Caredx Inc Stock (CDNA) Financials Data
Revenue
Net Income
Cash Flow
EPS
Caredx Inc Stock (CDNA) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| PETER MAAG | Director |
Aug 14 '26 |
Proposed Sale |
45.30 |
7,000 |
317,113 |
0 |
| PETER MAAG | Director |
Aug 13 '26 |
Proposed Sale |
47.07 |
7,000 |
329,505 |
0 |
| PETER MAAG | Director |
Aug 12 '26 |
Proposed Sale |
46.89 |
7,000 |
328,238 |
0 |
| PETER MAAG | Director |
Aug 11 '26 |
Proposed Sale |
47.69 |
7,000 |
333,851 |
0 |
| PETER MAAG | Director |
Aug 10 '26 |
Proposed Sale |
47.66 |
6,902 |
328,949 |
0 |
| ARTHUR TORRES | Director |
Aug 10 '26 |
Proposed Sale |
47.73 |
4,200 |
200,475 |
0 |
| PETER MAAG | Director |
Aug 07 '26 |
Proposed Sale |
45.83 |
27,332 |
1,252,492 |
0 |
| GEORGE W BICKERSTAFF | Director |
Aug 05 '26 |
Proposed Sale |
46.28 |
20,000 |
925,700 |
0 |
| Bickerstaff George | Director |
Aug 05 '26 |
Sale |
46.28 |
20,000 |
925,700 |
134,061 |
| Novack Jeffrey Adam | Secretary and General Counsel |
Aug 05 '26 |
Sale |
46.26 |
2,688 |
124,349 |
106,075 |
2.68%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):